![]() |
Volumn 15, Issue 3, 2001, Pages 595-597
|
Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOOXYGENASE 2;
DEXAMETHASONE;
FLURBIPROFEN;
I KAPPA B;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
ISOENZYME;
LIPOPOLYSACCHARIDE;
MESSENGER RNA;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN E2;
PROSTAGLANDIN SYNTHASE;
TRANSCRIPTION FACTOR AP 1;
ZYMOSAN;
ACTIVE TRANSPORT;
ANIMAL;
ARTICLE;
CELL LINE;
CHEMISTRY;
DRUG EFFECT;
GENETICS;
INFLAMMATION;
MACROPHAGE;
METABOLISM;
MOUSE;
PHOSPHORYLATION;
RAT;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SPINAL CORD;
STEREOISOMERISM;
WESTERN BLOTTING;
ACTIVE TRANSPORT, CELL NUCLEUS;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BLOTTING, WESTERN;
CELL LINE;
CYCLOOXYGENASE 2;
DEXAMETHASONE;
DINOPROSTONE;
FLURBIPROFEN;
I-KAPPA B PROTEINS;
INFLAMMATION;
ISOENZYMES;
LIPOPOLYSACCHARIDES;
MACROPHAGES;
MICE;
NF-KAPPA B;
PHOSPHORYLATION;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
RATS;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
RNA, MESSENGER;
SPINAL CORD;
STEREOISOMERISM;
TRANSCRIPTION FACTOR AP-1;
ZYMOSAN;
MLCS;
MLOWN;
|
EID: 0035291467
PISSN: 08926638
EISSN: None
Source Type: Journal
DOI: 10.1096/fasebj.15.3.595 Document Type: Article |
Times cited : (58)
|
References (0)
|